Menin Reduces Parvalbumin Expression and is Required for the Anti-Depressant Function of Ketamine.
Lige LengKai ZhuangHui LinJinjun DingShangchen YangZiqi YuanChangquan HuangGuimiao ChenZhenlei ChenMengdan WangHan WangHao SunHuifang LiHe ChangZhenyi ChenQi XuTifei YuanWenting XiePublished in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Dysfunction of parvalbumin (PV) neurons is closely involved in depression, however, the detailed mechanism remains unclear. Based on the previous finding that multiple endocrine neoplasia type 1 (Protein: Menin; Gene: Men1) mutation (G503D) is associated with a higher risk of depression, a Menin-G503D mouse model is generated that exhibits heritable depressive-like phenotypes and increases PV expression in brain. This study generates and screens a serial of neuronal specific Men1 deletion mice, and found that PV interneuron Men1 deletion mice (PcKO) exhibit increased cortical PV levels and depressive-like behaviors. Restoration of Menin, knockdown PV expression or inhibition of PV neuronal activity in PV neurons all can ameliorate the depressive-like behaviors of PcKO mice. This study next found that ketamine stabilizes Menin by inhibiting protein kinase A (PKA) activity, which mediates the anti-depressant function of ketamine. These results demonstrate a critical role for Menin in depression, and prove that Menin is key to the antidepressant function of ketamine.
Keyphrases
- poor prognosis
- pain management
- depressive symptoms
- mouse model
- bipolar disorder
- spinal cord
- genome wide
- middle aged
- sleep quality
- gene expression
- signaling pathway
- dna methylation
- type diabetes
- adipose tissue
- metabolic syndrome
- high grade
- wild type
- insulin resistance
- transcription factor
- blood brain barrier
- genome wide identification
- functional connectivity